Cancer and Covid-19 in the Department of Internal Medicine and Medical Oncology at the National Teaching Hospital Hubert Koutoukou Maga of Cotonou, about 4 Cases: A Review of the Literature
Coronavirus Disease-19 (COVID-19) manifests itself by a respiratory attack that can go from mild to severe forms. The factors favoring the severe forms are age, arterial hypertension, diabetes mellitus, and cancer. We report 4 cases of COVID-19 on cancer, followed in the Department of Internal Medicine and Medical Oncology of National Teaching Hospital Center Hubert Kougougou Maga (NTHC-HKM). Case 1: A hypertensive 65-year-old female patient with a severe form of COVID-19 on an FIGO (International Federation of Gynecology and Obstetrics) IVB endometrioid adenocarcinoma with pulmonary metastasis: unfavorable evolution under treatment with death. Case 2: A 56-year-old hypertensive patient with severe COVID-19 with pulmonary metastatic recurrence of SBRIII, HER2 positive invasive ductal carcinoma of the left breast: favorable evolution with cure of COVID-19, subsequent death related to active tumor. Case 3: A 37-year-old patient with a moderate form of COVID-19 with hepatocellular carcinoma complicating post alcoholic cirrhosis, CHILD C: favorable evolution with cure of COVID-19, patient lost to follow-up. Case 4: A 56-year-old patient, hypertensive, type II diabetic, presenting a severe form of COVID-19 on a field of ovarian serous adenocarcinoma of high grade FIGO IV A with pleuropulmonary metastasis: favorable evolution with cure of COVID-19, subsequent stroke, patient followed in palliative home hospitalization. The diagnosis of COVID-19 in cancer with pulmonary metastases is difficult. The pulmonary location of tumors seems to be a factor favoring severe forms.
References
[1]
El Amrani, M., Truant, S. and Turpin, A. (2020) COVID-19 and Cancer: What Are the Consequences of the Cancer Care Reorganization? Bulletin du Cancer, 107, 538-540. https://doi.org/10.1016/j.bulcan.2020.04.001
[2]
CDC Covid-19 Response Team, et al. (2020) Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions among Patients with Coronavirus Disease 2019-United States, February 12-March 28, 2020. Morbidity and Mortality Weekly Report, 69, 382-386. https://doi.org/10.15585/mmwr.mm6913e2
[3]
The French Cancer Society (2021) COVID and Cancer. SFC. https://sfc.asso.fr/informations-covid19/
[4]
Yu, J., Ouyang, W., Chua, M.L.K., et al. (2020) SARS-CoV-2 Transmission in Patients with Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncology, 6, 1108-1110. https://doi.org/10.1001/jamaoncol.2020.0980
[5]
Zhang, L., Zhu, F., Xie, L., et al. (2020) Clinical Characteristics of COVID-19-Infected Cancer Patients: A Retrospective Case Study in Three Hospitals within Wuhan, China. Annals of Oncology, 31, 894-901. https://doi.org/10.1016/j.annonc.2020.03.296
[6]
Kutikov, A., Weinberg, D.S., Edelman, M.J., et al. (2020) A War on Two Fronts: Cancer Care in the Time of COVID-19. Annals of Internal Medicine, 172, 756-758. https://doi.org/10.7326/M20-1133
[7]
Liang, W., Guan, W., Chen, R., et al. (2020) Cancer Patients in SARS-CoV-2 Infection: A Nationwide Analysis in China. The Lancet Oncology, 21, 335-337. https://doi.org/10.1016/S1470-2045(20)30096-6
[8]
Dai, M., Liu, D., Liu M., et al. (2020) Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discovery, 10, 783-791. https://doi.org/10.1158/2159-8290.CD-20-0422
[9]
Rodrigues, M. (2020) COVID-19 and Cancers. Summary of French Guidelines from Medical Societies and Their Evolution. Bull Cancer, 107, 521-523. https://doi.org/10.1016/j.bulcan.2020.04.008
[10]
Kuderer, N.M., Choueiri, T.K., Shah, D.P., et al. (2020) Clinical Impact of COVID-19 on Patients with Cancer (CCC19): A Cohort Study. The Lancet, 395, 1907-1918. https://doi.org/10.1016/S0140-6736(20)31187-9
[11]
Republic of Benin, Ministry of Health (2021) National Therapeutic Protocol for the Management of COVID-19 Patients at the CTE Allada (04/09/2021).